The treatment of epidermal necrolysis in pediatric patients remains a major challenge. Cyclosporine A has emerged as a promising therapy for epidermal necrolysis in adults; however, its efficacy in children is unclear. We present the case of a boy with Stevens-Johnson syndrome/toxic epidermal necrolysis overlap syndrome who was initially resistant to methylprednisolone monotherapy but improved after receiving the combination of cyclosporine A and methylprednisolone. Published reports on the use of cyclosporine A for pediatric epidermal necrolysis are also briefly reviewed.
CITATION STYLE
Dewi, S. T., Qomariah, L. N., Sarkowi, W. K., Puspitasari, M., Khalidah, M., Anggatama, M., … Febriana, S. A. (2023). Combination of cyclosporine A and methylprednisolone to treat pediatric Stevens-Johnson syndrome/toxic epidermal necrolysis overlap syndrome. Dermatology Reports, 15(2). https://doi.org/10.4081/dr.2023.9656
Mendeley helps you to discover research relevant for your work.